Coronavirus Vaccine

Judge Denies Kennedy's Request To Restore His Vaccine Videos On Youtube
The Week Ahead In Biotech: Decision Day For Bausch Health, IPO Flow Resumes, Oncology Conference
AstraZeneca Resumes Coronavirus Vaccine Trials In U.K. After Independent Committee Approves of Safety
The Week Ahead In Biotech: Decision Day For Bausch Health, IPO Flow Resumes, Oncology Conference
AstraZeneca Resumes Coronavirus Vaccine Trials In U.K. After Independent Committee Approves of Safety
AstraZeneca COVID-19 Vaccine Candidate Moves Into Late-Stage US Clinical Trials With 30,000 Participants
Elon Musk Heads To Germany To Assess Tesla Giga Berlin, Vaccine Printer Progress

Coronavirus Vaccine Recent News

AstraZeneca, Novavax, Pfizer, Others Lobby EU For Legal Protection Against COVID-19 Vaccine Liabilities: FT
COVID-19 vaccine makers are lobbying the European Union for protection against lawsuits should problems arise with new therapies, the Financial Times reported Tuesday.
Ex-FDA Commissioner Analyzes Johnson & Johnson's Mega Vaccine Trial
Johnson & Johnson (NYSE: JNJ) plans on enrolling up to 60,000 people in a coronavirus vaccine trial, likely as part of a global development and regulatory approval strategy, ex-FDA Commissioner Scott Gottlieb said Friday on
Pfizer, BioNTech Say Second Coronavirus Vaccine Shows Fewer Side Effects Than Their First Candidate
Pfizer Inc (NYSE: PFE), and its partner BioNTech SE (NASDAQ: BNTX), announced positive results for the Phase 1 trial of their second COVID-19 vaccine candidate, stating that the latest vaccine candidate had fewer side effe
CanSino Gets China's First COVID-19 Vaccine Patent
CanSino Biologics Inc (OTC: CASBF) has become the first company to secure a patent for its COVID-19 vaccine in China, Reuters 
Novavax To Supply 60M Coronavirus Vaccine Doses To UK Under New Deal
Novavax, Inc (NASDAQ: NVAX) announced Friday it has reached terms with the government of the United Kingdom to supply 60 million doses of its COVID-19 vaccine, when, and if, it receives regulatory approval.
AstraZeneca Inks Deal With Mexico, Argentina For Production, Supply Of Its COVID-19 Vaccine To Latin America
AstraZeneca plc’s (NYSE: AZN) COVID-19 vaccine will be produced by Mexico and Argentina for Latin American countries except for Brazil, according to government officials of the two countries, AlJazeera reported Wednesday.
Activist Investor Nelson Peltz Says He Is Putting New Capital To Work
Activist investor and Trian Partners CEO Nelson Peltz told CNBC on Thursday's "Halftime Report" he bought shares of unnamed companies that were "beaten down too much."
Novavax Continues Huge Run, Short Seller Sees It Falling Back To $15
Shares of Novavax, Inc. (NASDAQ: NVAX) gained more than 25% by Monday, leading a notable short seller to tweet his thoughts on the stock.